Medmal (Medical malpractice)
-
The FTC granted early termination of the waiting period, leaving the acquisition on track to finish in early 2026. -
The vote paves the way for the finalization of the deal in the first half of 2026.
-
Tariffs could drive up property loss costs, but the impact on other items has been muted.
-
The impact of SAM claims is reverberating through the tower and the broader marketplace beyond hospitals.
-
A deep-dive analysis shows LitFin is not the boogeyman this industry paints it out to be.
-
The Insurance Insider US news team runs you through this week’s key agency M&A.
-
What insurers can learn from the history that led to this deal.
-
ProAssurance brands will be transitioned to The Doctors Company in "all/most markets" over time.
-
The Californian insurer is buying the medmal carrier for $25.00 per share, or a ~60% premium.
-
The executive is returning to Tysers after nearly four years at Price Forbes.
-
Profitability over growth continues to be the company’s “mantra”.
-
Frequency has rebounded, while severity has spiked beyond the pre-Covid-19 years.
Related
-
Sexual abuse and molestation claims drive tightening medmal market
November 19, 2024 -
ProAssurance Q3 NWP declined in part due to Lloyd’s exit: CFO
November 08, 2024 -
Beazley halts offering new capacity for hospitals
October 16, 2024 -
Medical care CPI fell 0.1% in August after 0.2% decline in July
September 11, 2024 -
H1 commercial lines data: OL loss ratio spikes to highest in 11 years
September 10, 2024